Hidden virus threat in dual organ transplants revealed
NCT ID NCT05224583
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study reviews medical records of 50 adults who received a simultaneous liver-kidney transplant between 2015 and 2020. Researchers want to find out how many of them developed BK virus in their blood, which can harm the new kidney. The goal is to better understand this risk in dual-organ transplant patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand and manage BK virus risks in combined liver-kidney transplant patients.
- What could go wrong
- This is a small, single-center review of past records, not a treatment trial. Results may not apply to all transplant centers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BK VIREMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may spot hidden kidney transplant rejection
- Transplant breakdown? new study checks organ fluid for hidden germs
- Kidney transplant patients' immune response to common virus tracked after drug switch
- Immune cells may predict CMV relapse in kidney transplant patients
- Harmless virus levels may predict transplant complications
- Kidney transplant virus filter trial pulled before start